Education
About Us
Working with TipRanks
Follow Us
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
RESEARCH TOOLSreports
Technical Sentiment
Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
Adaptimmune Therapeutics’s (ADAP) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting Adaptimmune Therapeutics is a Sell.
Adaptimmune Therapeutics’s (ADAP) 20-Day exponential moving average is 0.27, while Adaptimmune Therapeutics’s (ADAP) share price is $0.24, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 50-Day exponential moving average is 0.38, while Adaptimmune Therapeutics’s (ADAP) share price is $0.24, making it a Sell.
Adaptimmune Therapeutics (ADAP) Pivot Points
Classic
0.20
0.21
0.23
0.24
0.26
0.27
0.28
Fibonacci
0.21
0.22
0.23
0.24
0.25
0.26
0.27
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.
Adaptimmune Therapeutics (ADAP) Moving Averages
MA5
0.24Buy
0.24Buy
MA10
0.24Buy
0.24Sell
MA20
0.25Sell
0.27Sell
MA50
0.41Sell
0.38Sell
MA100
0.51Sell
0.50Sell
MA200
0.76Sell
0.72Sell
Adaptimmune Therapeutics’s (ADAP) 10-Day exponential moving average is 0.24, while Adaptimmune Therapeutics’s (ADAP) share price is $0.24, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) 100-Day exponential moving average is 0.50, while Adaptimmune Therapeutics’s (ADAP) share price is $0.24, making it a Sell.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.24 and Adaptimmune Therapeutics’s (ADAP) 50-day simple moving average is 0.41, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.24 and Adaptimmune Therapeutics’s (ADAP) 100-day simple moving average is 0.51, creating a Sell signal.
Adaptimmune Therapeutics’s (ADAP) stock price is $0.24 and Adaptimmune Therapeutics’s (ADAP) 200-day simple moving average is 0.76, creating a Sell signal.
Adaptimmune Therapeutics (ADAP) Technical Indicators
RSI (14)
37.69
Neutral
STOCH (9,6)
34.62
Neutral
STOCHRSI (14)
35.80
Neutral
MACD (12,26)
-0.05
Sell
ADX (14)
31.70
Neutral
Williams %R
-66.67
Buy
CCI (14)
-22.02
Neutral
ATR (14)
0.04
-
Ultimate Oscillator
50.77
Neutral
ROC
14.29
Buy
Adaptimmune Therapeutics’s (ADAP) Relative Strength Index (RSI) is 37.69, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Trend Strength Indicator (ADX) is 31.70, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Commodity Channel Index (CCI) is -22.02, creating a Neutral signal.
Adaptimmune Therapeutics’s (ADAP) Price Rate of Change (ROC) is 14.29, creating a Buy signal.
FAQ
Is ADAP a Buy, Hold, or Sell?
Based on ADAP’s technical indicators, ADAP is a Sell.
What is ADAP’s RSI (14)?
ADAP’s RSI (14) is 37.69, which suggests ADAP is a Neutral.
What is ADAP’s MACD?
ADAP’s MACD is -0.05, which suggests ADAP is a Sell.
What is ADAP’s 5-day moving average?
ADAP’s 5-day moving average is 0.24, which suggests ADAP is a Buy.
What is ADAP’s 20-day moving average?
ADAP 20-day moving average is 0.25, which suggests ADAP is a Sell.
What is ADAP’s 50-day moving average?
ADAP’s 50-day moving average is 0.41, which suggests ADAP is a Sell.
What is ADAP’s 200-day moving average?
ADAP’s 200-day moving average is 0.76, which suggests ADAP is a Sell.
What is ADAP’s Williams % R (14)?
ADAP’s Williams % R (14) is -66.67, which suggests ADAP is a Buy.
What is ADAP’s CCI (14)?
ADAP’s CCI (14) is -22.02, which suggests ADAP is a Neutral.